Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience.
Sebestyén E, Major N, Bodoki L, Makai A, Balogh I, Tóth G, Orosz Z, Árkosy P, Vaskó A, Hodosi K, Szekanecz Z, Szekanecz É.
Sebestyén E, et al. Among authors: szekanecz z, szekanecz e.
Front Oncol. 2023 Oct 17;13:1252215. doi: 10.3389/fonc.2023.1252215. eCollection 2023.
Front Oncol. 2023.
PMID: 37916172
Free PMC article.